Markozannes, Georgios
Kanellopoulou, Afroditi
Dimopoulou, Olympia
Kosmidis, Dimitrios
Zhang, Xiaomeng
Wang, Lijuan
Theodoratou, Evropi
Gill, Dipender
Burgess, Stephen
Tsilidis, Konstantinos K.
Funding for this research was provided by:
Cancer research UK (C18281/A29019)
Wellcome Trust (204623/Z/16/Z)
NIHR Cambridge Biomedical Research Centre (BRC-1215-20014)
Cancer Research UK Career Development Fellowship (C31250/A22804)
Article History
Received: 8 September 2021
Accepted: 10 January 2022
First Online: 2 February 2022
Declarations
:
: Not required.
: Not applicable.
: DG is employed part-time by Novo Nordisk, outside and unrelated to the current work; the rest of the authors declare that they have no competing interests.